FAQ Library

FAQ Library published on June 13, 2017
Dr. Bekaii-Saab discusses emerging agents that are designed to target the stroma in patients with advanced metastatic pancreatic cancer.
FAQ Library published on December 7, 2016
Dr. Bruera provides insight into the best practices for talking with your patients with advanced cancer.
FAQ Library published on November 9, 2016
Are you wondering about the current status of adjuvant therapy in patients who undergo resection for pancreatic cancer? Dr. Margaret A. Tempero provides an answer to this frequently asked question.
FAQ Library published on October 5, 2016
Dr. Alok Khorana explains what initial assessment is recommended before initiating therapy after a histopathologic confirmation of pancreatic adenocarcinoma.
FAQ Library published on September 7, 2016
Join Dr. Alok Khorana as he explains the appropriate time to initiate palliative care services in patients with pancreatic cancer based on ASCO’s Pancreatic Cancer Guidelines.
FAQ Library published on August 4, 2016
Learn some of the best pain management strategies for patients with pancreatic cancer from leading pain expert Jeffrey A. Gudin.
FAQ Library published on July 6, 2016
Dr. Philip A. Philip shares his insight on the therapeutic efficacy in treatments that target epidermal growth factor receptor signaling in pancreatic cancer.
FAQ Library published on June 7, 2016
Learn which pancreatic cancer patients should be referred to a clinical trial and which patients should not in this quick practical answer by Dr. Margaret Tempero.
FAQ Library published on May 11, 2016
Are you wondering if immune checkpoint inhibitors have a demonstrated efficacy in patients with pancreatic cancer? Dr. Philip A. Philip shares his perspective on this question.
FAQ Library published on April 13, 2016
In this FAQ, Dr. O'Reilly provides the key take away points from the genome study identifying four molecular subtypes in pancreatic cancer.
Page 2 of 6
Results 11 - 20 of 55